Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02MXT
|
||||
Former ID |
DIB013268
|
||||
Drug Name |
MK-2894
|
||||
Synonyms |
EP4 antagonists (inflammatory pain); L-161982; MF-310; MF-498; MF-592; MF-766; MK-2894; EP4 antagonists (inflammatory pain), Merck Frosst Canada; Prostaglandin E2 subtype 4 receptor antagonists (pain/inflammation), Merck Frosst
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [541165] | ||
Company |
Merck Frosst Canada & Co
|
||||
Structure |
Download2D MOL |
||||
Formula |
C25H22F3NO3S
|
||||
InChI |
InChI=1S/C25H22F3NO3S/c1-14-20(13-16-3-7-19(8-4-16)25(26,27)28)21(15(2)33-14)22(30)29-24(11-12-24)18-9-5-17(6-10-18)23(31)32/h3-10H,11-13H2,1-2H3,(H,29,30)(H,31,32)
|
||||
InChIKey |
QJZQFVRFJCGDKF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin E2 receptor, EP4 subtype | Target Info | Antagonist | [543780] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.